Cancer Immunology and Immunotherapy

Cancer immunology explores how tumours evade immune surveillance and manipulate the immune microenvironment to promote growth and survival. It investigates immune checkpoint pathways (e.g., PD-1/PD-L1) that inhibit anti-tumour immune responses and immunosuppressive mechanisms within the tumour microenvironment. Immunotherapy strategies aim to activate and enhance the body's immune responses against cancer, including checkpoint inhibitors, adoptive cell therapies like CAR-T cells, cytokine therapies, and therapeutic vaccines. These approaches harness the immune system's potential to recognize and eliminate cancer cells, offering new treatment options and improving outcomes for cancer patients.

    Related Conference of Cancer Immunology and Immunotherapy

    September 22-23, 2025

    6th World Congress on Neuroimmunology and Neuroinfectious Diseases

    Amsterdam, Netherlands
    October 16-17, 2025

    39th International Conference on Immunology

    Amsterdam, Netherlands
    May 18-19, 2026

    17th Global Summit on Immunology and Cell Biology

    Paris, Aland Islands

    Cancer Immunology and Immunotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in